|
|
|
Volumn 123, Issue SUPPL. 5, 1998, Pages 156-158
|
|
Primary chemotherapy of metastatic breast cancer with bendamustine hydrochloride, methotrexate and fluorouracil versus cyclophosphamide, methotrexate and fluorouracil;Primare Chemotherapie des metastasierenden Mammakarzinoms mit Bendamustinhydrochlorid, Methotrexat und Fluorouracil versus Cyclophosphamid, Methotrexat und Fluorouracil
|
|
Author keywords
Bendamustine; Breast cancer; Chemotherapy; Cyclophosphamide
|
|
Indexed keywords
BENDAMUSTINE;
CYCLOPHOSPHAMIDE;
FLUOROURACIL;
METHOTREXATE;
ANTINEOPLASTIC AGENT;
CHLORMETHINE DERIVATIVE;
CMF REGIMEN;
BREAST CANCER;
BREAST METASTASIS;
CANCER CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER REGRESSION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ARTICLE;
BREAST TUMOR;
COMPARATIVE STUDY;
FEMALE;
METASTASIS;
MORTALITY;
PATHOLOGY;
PILOT STUDY;
SALVAGE THERAPY;
SURVIVAL RATE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CYCLOPHOSPHAMIDE;
FEMALE;
FLUOROURACIL;
HUMANS;
METHOTREXATE;
NEOPLASM METASTASIS;
NITROGEN MUSTARD COMPOUNDS;
PILOT PROJECTS;
SALVAGE THERAPY;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 0032435238
PISSN: 0044409X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (12)
|
|
References (7)
|
